|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01K 67/027 | |
| C12N 15/85 | |||
| C12N 9/64 | |||
| C07K 16/00 |
| (11) | Number of the document | 2989894 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15188522.5 |
| Date of filing the European patent application | 2012-11-30 | |
| (97) | Date of publication of the European application | 2016-03-02 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201113310431 | 2011-12-02 | US | |
| 201122047 | 2011-12-21 | GB | |
| 201213416684 | 2012-03-09 | US |
| (72) |
FRIEDRICH, Glenn A., GB
LEE, E-Chiang, GB
|
| (73) |
Kymab Limited,
The Bennet Building (B930) Babraham Research Campus, Cambridge CB22 3AT,
GB
|
| (54) | USE OF FERTILE TRANSGENIC MICE OR RATS FOR PRODUCING ANTIBODIES BEARING HUMAN VARIABLE REGIONS |
| USE OF FERTILE TRANSGENIC MICE OR RATS FOR PRODUCING ANTIBODIES BEARING HUMAN VARIABLE REGIONS |